ELAB - Company ID 0001840563
The table below shows Elevai Labs Inc.'s income statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $590.08K | - | $1.71M | $766.28K |
| Cost of revenue | $404.77K | - | $1.71M | $318.97K |
| Gross profit | $185.31K | - | $1.13M | $447.31K |
| R&D | $147.01K | $104.65K | $7.41K | $228.75K |
| SG&A | $2.24M | $1.09M | $347.65K | $1.02M |
| Operating income | - | - | - | - |
Elevai Labs Inc. reported annual revenue of $590.08K for fiscal year 2025. That is down 65.5% from $1.71M in fiscal 2023. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Income tax |
| $30.97K |
| - |
| - |
| - |
| Net income | -$7.75M | -$6.25M | -$4.30M | -$1.80M |
| EPS (diluted) | - | - | -$0.40 | -$0.19 |